On September 30, 2024 Johnson & Johnson (J&J) announced it was ending its plans to implement a 340B rebate model for two of its drugs, Stelara and Xarelto. The immediate halt to the rebate model was prompted by the Health Resources and Services Administration’s (HRSA) September 27 letter threatening to terminate J&J’s participation in the…
In Florida, 340B helps address a common need across diverse communities: access to affordable healthcare and medications. Melissa Allen Davis, 340B Program Coordinator at Florida Community Health Centers, sees the program benefits daily in her community. At Florida Community Health Centers, letting patients know about 340B has made them more willing to engage in campaigns…
With over 30 years of experience working for non-profit health systems, Lisa Fratesi gives us a firsthand account of the 340B Program’s tremendous impact since its start, how it has evolved, the challenges 340B covered entities face today, and what her organization is doing to #Defend340B. How 340B Started In 1992, section 340B of…
Savings from the 340B program are instrumental in allowing MedStar Health to meet the ever-evolving needs of the Washington, D.C., Maryland, and Virginia metropolitan area communities. by MedStar Health July 2024 As new care needs of the community become evident, 340B savings are utilized to invest in both a pharmacy discount program to provide…
A 340B Program Assistant Director shares how the federal 340B program could have saved the lives of her mother and other low-income Medicaid patients. by Kelli Pardee, MBA, CPhT 340B Program Assistant Director, Great Lakes Bay Health Centers May 2024 My name is Kelli Pardee, and I am a 340B Program Assistant Director at…
In a recent guest opinion essay published in the New York Times, Dr. Lindsay Ryan, University of California, argues that end-stage poverty is killing Americans. Dr. Ryan is an associate physician at the University of California, San Francisco, Department of Medicine. It is a safety-net hospital, which Dr. Ryan describes as “institutions that disproportionately serve…
Black Pharmacists Advocate for 340B For over 30 years, the federal 340B Drug Pricing program (340B) has enabled covered entities to be the healthcare safety-net for vulnerable Americans. The Los Angeles Sentinel recently published an article by three black pharmacists, Dr. Kenneth Schell, Dr. John Clark, and Dr. Anthony Jackson. In the article, they…
A New Groundbreaking Study Reveals Real-Life Impact, Cost Savings, and Barriers Faced by Underserved Diabetes Patients in Safety-Net Clinics The federal 340B Drug Pricing Program provides discounted drug prices to safety-net entities, enabling them to serve more vulnerable patients. This program has become indispensable with the escalating costs of medications, including high-cost injectable diabetes…
Five Horizons Health Services Provides HIV Prevention in West Alabama & East Mississippi with 340B The 340B Program allows the rural healthcare facility to provide high-quality, patient-centered medical, dental, prevention, behavioral health, testing, and case management services. by Shey Thorn, MPH, Chief of Staff, Five Horizons Health Services October 2023 Five Horizons Health Services…
History of the 340B Program by Januari Fox, Director of Policy & Advocacy, Community Engagement, Prism Health North Texas Administration October 2022 Republished from the Dallas Medical Journal. Find the original article here. A little-known program that establishes pathways of care for underserved communities is under attack by drug manufacturers. Created in 1992, the…